Latest News From Hematology
The following represent additions to UpToDate from the past six months that were considered by the editors and authors to be of particular interest. The most recent What’s New entries are at the top of each subsection.
New drug combination targets aggressive blood cancer
Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial GRAND RAPIDS, Mich. (March 7, 2017)—A pair of drugs that may be a one-two punch needed to help combat acute…Read More
Van Andel Institute–SU2C
Cancer Epigenetics Dream Team:
The Epigenetics Dream Team II
Epigenetic therapy is an approach to cancer treatment that involves switching key genes on or off to help destroy cancer cells. The Van Andel Institute (VAI)–SU2C Cancer Epigenetics Dream Team II, funded by the Van Andel Institute, continues the original…Read More
TARGETing pediatric blood cancer: Changing treatment for kids
A new molecular map of pediatric acute myeloid leukemia (AML) illuminates previously unknown causes of the disease and may lead to more effective treatment strategies developed specifically for children. Conducted by an international team of scientists and pediatric oncologists, the…Read More